CYRX: היקף החוב לטווח ארוך Cryoport Systems

Cryoport, Inc. (CYRX) is developing a unique IT environment for temperature control in biopharmaceuticals, where the integration of Cryoportal with cryo-containers makes switching providers critically risky. This price chart confirms the asset's dynamics, while long-term debt stands at 0.04. The business is scaling its infrastructure for the global cell therapy market, successfully bypassing geopolitical barriers by focusing on the secure zones of the US and its allies.

Analyzing the borrowing structure serves as a critical filter for assessing an issuer's financial stability. This metric aggregates all credit obligations with maturities exceeding twelve months, reflecting the long-term debt load. The trend in the company's long-term debt statistics allows for the differentiation of investment growth from the risks of excessive leverage. For Cryoport, Inc. (CYRX), these funds serve as the foundation for scaling specialized cryogenic logistics and developing IT monitoring for biomaterials.